logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rafael Morales-Barrera

University of London
H指数:32
被引数:5,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma)

一项Ib/II期、开放标签、多中心、随机伞式研究，评估阿替利珠单抗与萨喜妥珠单抗戈维他胺联用对既往接受过铂类治疗方案治疗的局部晚期或转移性尿路上皮癌患者的疗效（MORPHEUS-Urothelial Carcinoma）

ESMO Open
IF8.3
2026-07-010
OAAI
Shin, S. J.; Lee, J. L.; Powles, T.; Martin-Liberal, J.; Morales-Barrera, R.; Drakaki, A.; Friedlander, T.; Joly, F.; Shah, S. A.; Vuky, J.; Ianculescu, I.; Michielin, F.; Gan, X.; Bamias, A.
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression

EMETPRO：一项多中心、国际性回顾性分析，评估早期进展的转移性激素敏感性前列腺癌患者

Prostate Cancer and Prostatic Diseases
IF5.8
2026-05-290
PRE
Fabio Turco; Silke Gillessen; Giuseppe Salfi; Iris S. H. Kloots; Peter H. J. Slootbeek; Niven Mehra; Matthew Labriola; Daniel J. George; Amanda Broderick; Anna Patrikidou; Hortense Patry; Consuelo Buttigliero; Veronica Crespi; Hirotsugu Uemura; Kazutoshi Fujita; Takanobu Utsumi; Hiroyoshi Suzuki; Daniele Raggi; Umberto Basso; Rafael Morales-Barrera; David Marmolejo Castaneda; Cora N. Sternberg; Daniela Guevara; Orazio Caffo; Giuseppe Procopio; Andrea Zivi; Sara Merler; Mariella Sorarù; Daniel E. Spratt; Pedro C. Barata; Carlo Messina; Yüksel ürün; Hatice Bolek; Ignacio Duràn; Juan Diego Cacho Lavin; Nieves Martínez Chanzá; Lisa G. Horvath; Rhiannon Mellor; Levent Türkeri; Merve Bengisu Soykök; Sabrina Rossetti; Richard Cathomas; Giuseppe Luigi Banna; Vincenza Conteduca; Margaret Ottaviano; Laura Marandino; Hui-Ming Lin; Luigi Tortola; Ricardo Pereira Mestre; Martino Pedrani
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract

TROPiCS-04研究的通俗语言摘要：沙西妥珠单抗在铂类化疗和免疫疗法之后，用于患有膀胱、尿道或上尿路局部晚期或转移性癌症的人群

FUTURE ONCOLOGY
IF2.6
2025-11-011
PRE
Powles, Thomas; Tagawa, Scott T.; Vulsteke, Christof; Gross-Goupil, Marine; Park, Se Hoon; Necchi, Andrea; De Santis, Maria; Duran, Ignacio; Morales-Barrera, Rafael; Guo, Jun; Sternberg, Cora N.; Bellmunt, Joaquim; Goebell, Peter J.; Kovalenko, Maria; Boateng, Freda; Sierecki, Mitch; Wang, Lu; Sima, Camelia S.; Waldes, Jana; Bangs, Rick; Loriot, Yohann; Grivas, Petros
Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive review

权衡免疫检查点抑制剂在存在基础免疫介导性炎症性疾病患者中的风险与获益：一项综合综述

Critical Reviews in Oncology/Hematology
IF0
2025-10-300
PRE
Clara Salva de Torres; Ernesto Trallero-Araguas; David Marmolejo; José Maria Ucha Hermida; Nely Díaz Mejía; Pau Mascaró Baselga; Abraham André Arturo Geng-Cahuayme; Laia Catalan; Macarena González; Rafael Morales-Barrera; Joan Carles; Enrique Gallardo; Cristina Suárez
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer

ctDNA指导下的辅助阿特珠单抗治疗在肌肉浸润性膀胱癌中的应用

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2025-10-0110
PRE
Powles, Thomas; Kann, Ariel G.; Castellano, Daniel; Gross-Goupil, Marine; Nishiyama, Hiroyuki; Bracarda, Sergio; Bjerggaard Jensen, Jorgen; Makaroff, Lydia; Jiang, Shusuan; Ku, Ja Hyeon; Park, Se Hoon; Reig Torras, Oscar; Ye, Dingwei; Maruzzo, Marco; Necchi, Andrea; Morales-Barrera, Rafael; Giunta, Emilio Francesco; Lee, Jae Lyun; Tortora, Giampaolo; Urun, Yuksel; Dolowy, Lukasz; Erdem, Dilek; Pinto, Alvaro; Grando, Fabricio; Zou, Wei; Assaf, Zoe June; Vuky, Jacqueline; Degaonkar, Viraj; Steinberg, Elizabeth E.; Bellmunt, Joaquim; Gschwend, Jurgen E.
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study

卡博替尼治疗晚期肾细胞癌在西班牙和葡萄牙真实世界实践中的有效性与安全性：SOGUG-SPRWEC研究

CLINICAL GENITOURINARY CANCER
IF0
2025-09-010
PRE
Suarez, Cristina; Torras, Oscar Reig; Barrera, Rafael Morales; Sanchez, Angel Rodriguez; Palacios, Georgia Anguera; Manshino, Andre Miguel Branco; Nunez, Natalia Fernandez; Vidal, Maria Jose Mendez; Carbonero, Iciar Garcia; Calvo, Ovidio Fernandez; Sarrio, Regina Girones; Herrero, Guillermo Crespo; Afonso, Javier Afonso; Fita, Maria Jose Juan; Padro, Josep Guma; Quintela, Martin Lazaro; Rodriguez-Vida, Alejo; Perez, Carolina Hernandez; Colmenero, Ana Medina; Martin, Ricardo Collado; de Espana, Carmen Garcias; Palau, Carmen Molins; Ortega, Esther Martinez; Gallardo, Enrique
TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis

TROPiCS-04，一项关于sacituzumab govitecan（SG）与化疗（CT）对比治疗经治晚期尿路上皮癌（aUC）的随机III期研究：总生存期（OS）和安全性的分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-011
PRE
Grivas, P.; Powles, T. B.; Vulsteke, C.; Goupil, M. Gross; Park, S. H.; Necchi, A.; De Santis, M.; Duran, I.; Morales Barrera, R.; Guo, J.; Sternberg, C. N.; Bellmunt, J.; Goebell, P. J.; Boateng, F.; Sierecki, M.; Wang, L.; Sima, C.; Waldes, J.; Tagawa, S. T.; Loriot, Y.
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
CLINICAL CANCER RESEARCH
IF10.2
2024-10-300
OAAI
Flechon, Aude; Morales-Barrera, Rafael; Powles, Thomas; Alva, Ajjai; Ozguroglu, Mustafa; Csoszi, Tibor; Loriot, Yohann; Rodriguez-Vida, Alejo; Geczi, Lajos; Cheng, Susanna Y.; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Gunduz, Seyda; Mamtani, Ronac; Yu, Evan Y.; Montesa Pino, Alvaro; Anido, Urbano; Sendur, Mehmet A. N.; Gravis, Gwenaelle; Revesz, Janos; Kostorov, Vladimir; Huillard, Olivier; Ma, Junshui; Rajasagi, Mohini; Vajdi, Amir; Lunceford, Jared; Cristescu, Razvan; Imai, Kentaro; Homet Moreno, Blanca; Matsubara, Nobuaki
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

诱导avelumab，然后进行化学免疫疗法和维持与单独化疗作为顺式不合格转移性尿路上皮癌的一线治疗 (INDUCOMAIN): 一项随机II期研究

ESMO OPEN
IF8.3
2024-09-010
OAAI
Rodriguez-Vida, A.; Valderrama, B. P.; Castellano, D.; Pinto, A.; Mellado, B.; Puente, J.; Climent, M. A.; Domenech, M.; Vazquez, F.; Perez-Gracia, J. L.; Bonfill, T.; Morales-Barrera, R.; Gonzalez-Billalabeitia, E.; Garcia-del-Muro, X.; Maroto, P.; Navarro-Gorro, N.; Juanpere, N.; Juan, O.; Bellmunt, J.
Circulating tumor DNA (ctDNA) clearance with neoadjuvant durvalumab (D) plus tremelimumab (T) plus enfortumab vedotin (EV) for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) from the safety run-in cohort of the phase III VOLGA trial

VOLGA III期试验安全启动队列中，使用新辅助度伐利尤单抗（D）联合特瑞普利单抗（T）和恩沃利单抗（EV）治疗不适合顺铂的肌肉浸润性膀胱癌（MIBC）患者的循环肿瘤DNA（ctDNA）清除情况。

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Drakaki, A.; Powles, T. B.; Wang, Y.; Bupathi, M.; Joshi, M.; Fleming, M. T.; de Liano Lista, A. Gomez; Morales Barrera, R.; Pili, R.; Boulos, S.; Shrestha, Y.
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial

全身磁共振成像作为去势抵抗性前列腺癌骨转移的治疗反应生物标志物: iPROMET临床试验

EUROPEAN UROLOGY
IF25.2
2024-09-016
PRE
Garcia-Ruiz, Alonso; Macarro, Carlos; Zacchi, Francesca; Morales-Barrera, Rafael; Grussu, Francesco; Casanova-Salas, Irene; Sanguedolce, Francesco; Gonzalez, Macarena; Cresta-Morgado, Pablo; de Albert, Matias; Garcia-Bennett, Josep; Marmolejo, David; Planas, Jacques; Roche, Sarai; Mast, Richard; Zatse, Christina; Piulats, Josep M.; Herrera-Imbroda, Bernardo; Regis, Lucas; Agundez, Laura; Olmos, David; Calvo, Nahum; Escobar, Manuel; Carles, Joan; Mateo, Joaquin; Perez-Lopez, Raquel
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

223镭治疗的转移性去势抵抗性前列腺癌患者的骨代谢生物标志物和生存率的前瞻性评估: PRORADIUM研究

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-06-012
PRE
Romero-Laorden, Nuria; Lorente, David; de Velasco, Guillermo; Lozano, Rebeca; Herrera, Bernardo; Puente, Javier; Lopez, Pedro P.; Medina, Ana; Almagro, Elena; Gonzalez-Billalabeitia, Enrique; Villla-Guzman, Jose Carlos; Gonzalez-del-Alba, Aranzazu; Borrega, Pablo; Lainez, Nuria; Fernandez-Freire, Ana; Hernandez, Amaia; Rodriguez-Vida, Alejo; Chirivella, Isabel; Fernandez-Parra, Eva; Lopez-Campos, Fernando; Pacheco, Maria Isabel; Morales-Barrera, Rafael; Fernandez, Ovidio; Villatoro, Rosa; Luque, Raquel; Hernando, Susana; Castellano, Daniel C.; Castro, Elena; Olmos, David
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
BRITISH JOURNAL OF CANCER
IF6.8
2023-12-153
PRE
Font, Albert; Mellado, Begona; Climent, Miguel A.; Virizuela, Juan Antonio; Oudard, Stephane; Puente, Javier; Castellano, Daniel; Gonzalez-del-Alba, Aranzazu; Pinto, Alvaro; Morales-Barrera, Rafael; Rodriguez-Vida, Alejo; Fernandez, Pedro L.; Teixido, Cristina; Jares, Pedro; Aldecoa, Iban; Gibson, Neil; Solca, Flavio; Mondal, Shoubhik; Lorence, Robert M.; Serra, Josep; Real, Francisco X.
A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Grivas, P.; Sridhar, S.; Perez Valderrama, B.; Castellano Gauna, D. E.; Loriot, Y.; Doger de Speville, B.; Pouessel, D.; van der Heijden, M. S.; Galsky, M. D.; Gulati, S.; Ravaud, A.; Fontana, E.; Spira, A. I.; Gartrell, B. A.; Mortazavi, A.; Isambert, N.; Baxter, D.; Powles, T. B.; Khaled, A. H.; Morales Barrera, R.
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial

在一线醋酸阿比曲酮或恩扎鲁他胺治疗无症状骨转移的转移性去势抵抗性前列腺癌患者的镭223: 一项单臂II期试验

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-09-017
PRE
Carles, Joan; Alonso-Gordoa, Teresa; Mellado, Begona; Mendez-Vidal, Maria J.; Vazquez, Sergio; Gonzalez-del-Alba, Aranzazu; Piulats, Josep M.; Borrega, Pablo; Gallardo, Enrique; Morales-Barrera, Rafael; Paredes, Pilar; Reig, Oscar; Garcias de Espana, Carmen; Collado, Ricardo; Bonfill, Teresa; Suarez, Cristina; Sampayo-Cordero, Miguel; Malfettone, Andrea; Garde, Javier

研究方向

暂未获取到该数据
J
Joan Carles
H 指数:55论文数:717被引数:2.0万
A
Alejo Rodríguez‐Vida
H 指数:32论文数:227被引数:6,014
C
Cristina Suárez
H 指数:54论文数:376被引数:1.4万
P
Petros Grivas
H 指数:61论文数:916被引数:2.4万
I
Ignacio Durán
H 指数:54论文数:346被引数:1.6万
Y
Yohann Loriot
H 指数:76论文数:1,129被引数:5.3万
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万
A
Andrea Necchi
H 指数:70论文数:1,307被引数:3.2万
E
Evan Y. Yu
H 指数:60论文数:560被引数:2.2万
A
Ajjai Alva
H 指数:59论文数:458被引数:1.6万